Chronic prostatitis.

INTRODUCTION: Chronic prostatitis can cause pain and urinary symptoms, and usually occurs without positive bacterial cultures from prostatic secretions (known as chronic abacterial prostatitis or chronic pelvic pain syndrome [CP/CPPS]). Bacterial infection can result from urinary tract instrumentation, but the cause and natural history of CP/CPPS are unknown. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of treatments for chronic bacterial prostatitis? What are the effects of treatments for chronic abacterial prostatitis/chronic pelvic pain syndrome? We searched: Medline, Embase, The Cochrane Library, and other important databases up to August 2010 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). RESULTS: We found 33 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions. CONCLUSIONS: In this systematic review, we present information relating to the effectiveness and safety of the following interventions: 5 alpha-reductase inhibitors, allopurinol, alpha-blockers, biofeedback, local injections of antimicrobial drugs, mepartricin, nonsteroidal anti-inflammatory drugs (NSAIDs), oral antimicrobial drugs, pentosan polysulfate, prostatic massage, quercetin, radical prostatectomy, sitz baths, transurethral microwave thermotherapy, and transurethral resection. QUESTIONS What are the effects of treatments for chronic bacterial prostatitis?. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 What are the effects of treatments for chronic abacterial prostatitis/chronic pelvic pain syndrome?. . . . . . . . . 12 INTERVENTIONS CHRONIC BACTERIAL PROSTATITIS Likely to be beneficial Antimicrobial drugs (oral) for chronic bacterial prostatitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 Unknown effectiveness Alpha-blockers for chronic bacterial prostatitis . . . . . 7 Antimicrobial drugs (locally injected) for chronic bacterial prostatitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 NSAIDs for chronic bacterial prostatitis . . . . . . . . . 10 Radical prostatectomy for chronic bacterial prostatitis . 1 1 TURP for chronic bacterial prostatitis . . . . . . . . . . . 11 CHRONIC ABACTERIAL PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME (CP/CPPS) Unknown effectiveness 5 alpha-reductase inhibitors for chronic abacterial prostatitis/chronic pelvic pain syndrome . . . . . . . . . . . 19 Allopurinol for chronic abacterial prostatitis/chronic pelvic pain syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21 Alpha-blockers for chronic abacterial prostatitis/chronic pelvic pain syndrome . . . . . . . . . . . . . . . . . . . . . . . 12 Biofeedback for chronic abacterial prostatitis/chronic pelvic pain syndrome . . . . . . . . . . . . . . . . . . . . . . . 22 Mepartricin for chronic abacterial prostatitis/chronic pelvic pain syndrome . . . . . . . . . . . . . . . . . . . . . . . 22 NSAIDs for chronic abacterial prostatitis/chronic pelvic pain syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 Pentosan polysulfate for chronic abacterial prostatitis/chronic pelvic pain syndrome . . . . . . . . . . . . . . . 25 Quercetin for chronic abacterial prostatitis/chronic pelvic pain syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28 Sitz baths for chronic abacterial prostatitis/chronic pelvic pain syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 Transurethral microwave thermotherapy for chronic abacterial prostatitis/chronic pelvic pain syndrome . . 3 0 Unlikely to be beneficial Antimicrobial drugs (oral) for chronic abacterial prostatitis/chronic pelvic pain syndrome . . . . . . . . . . . . . . . 31 Prostatic massage for chronic abacterial prostatitis/chronic pelvic pain syndrome . . . . . . . . . . . . . . . . . . . . . 33

[1]  V. Škerk,et al.  Comparative Randomized Pilot Study of Azithromycin and Doxycycline Efficacy and Tolerability in the Treatment of Prostate Infection Caused by Ureaplasma urealyticum , 2005, Chemotherapy.

[2]  M. Pontari,et al.  A case‐control study of risk factors in men with chronic pelvic pain syndrome , 2005, BJU international.

[3]  V. Rivero,et al.  Reduced semen quality in chronic prostatitis patients that have cellular autoimmune response to prostate antigens. , 2005, Human reproduction.

[4]  G. Sant,et al.  Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. , 2005, The Journal of urology.

[5]  M. Pontari,et al.  Ciprofloxacin or Tamsulosin in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome , 2004, Annals of Internal Medicine.

[6]  M. Pontari,et al.  A randomized placebo‐controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis) , 2004, BJU international.

[7]  P. Narayan,et al.  Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. , 2004, The Journal of urology.

[8]  J. Nickel,et al.  Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. , 2003, Urology.

[9]  Shu-chen Wu,et al.  Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study. , 2003, Urology.

[10]  J. Nickel,et al.  Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. , 2003, Urology.

[11]  A. Schaeffer,et al.  The role of cytokines in prostatitis , 2003, World Journal of Urology.

[12]  M. Pontari,et al.  A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. , 2003, The Journal of urology.

[13]  J. Krieger,et al.  Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial. , 2003, The Journal of urology.

[14]  R. Nadler Bladder training biofeedback and pelvic floor myalgia. , 2002, Urology.

[15]  A. Schaeffer Classification (traditional and National Institutes of Health) and demographics of prostatitis. , 2002, Urology.

[16]  Weilie Hu,et al.  Treatment of chronic bacterial prostatitis with amikacin through anal submucosal injection. , 2002, Asian journal of andrology.

[17]  K. Naber Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis. , 2002, International journal of antimicrobial agents.

[18]  I. Mareković,et al.  Chronic Prostatitis Caused by Trichomonas vaginalis – Diagnosis and Treatment , 2002, Journal of chemotherapy.

[19]  J. Rajfer,et al.  Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. , 1999, Urology.

[20]  T. Wilt,et al.  Interventions for chronic abacterial prostatitis. , 1999, The Cochrane database of systematic reviews.

[21]  L. Nyberg,et al.  Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. , 1999, Urology.

[22]  O. Lukkarinen,et al.  Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a double-blind, placebo-controlled, pilot study. , 1999, Urology.

[23]  E. Nagy,et al.  The possible role of anaerobic bacteria in chronic prostatitis. , 1998, International journal of andrology.

[24]  M. Barry,et al.  How common is prostatitis? A national survey of physician visits. , 1998, The Journal of urology.

[25]  G. Nikiforidis,et al.  Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. , 1998, The Journal of urology.

[26]  R. Alexander,et al.  Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins. , 1997, Urology.

[27]  D. Bostwick,et al.  A review of clinical and pathological prostatitis syndromes. , 1997, Urology.

[28]  J. Nickel,et al.  Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double-blind sham controlled study using new prostatitis specific assessment questionnaires. , 1996, The Journal of urology.

[29]  G. Ronquist,et al.  Ameliorative effect of allopurinol on nonbacterial prostatitis: a parallel double-blind controlled study. , 1996, The Journal of urology.

[30]  J. Heiman,et al.  Sickness impact of chronic nonbacterial prostatitis and its correlates. , 1996, The Journal of urology.

[31]  P. Walsh,et al.  A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. , 1995, The Journal of urology.

[32]  J. J. de la Rosette,et al.  Personality variables involved in chronic prostatitis. , 1993, Urology.

[33]  J. Harris,et al.  Prostatodynia and herpes simplex virus infection. , 1991, Urology.

[34]  R. Golz,et al.  Candidosis of the prostate: a rare form of endomycosis , 1991, Mycoses.

[35]  P. Walsh,et al.  Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. , 1991, The Journal of urology.

[36]  B. Davis,et al.  Adenocarcinoma of the prostate discovered in 2 young patients following total prostatovesiculectomy for refractory prostatitis. , 1990, The Journal of urology.

[37]  C. Cox Ofloxacin in the management of complicated urinary tract infections, including prostatitis. , 1989, The American journal of medicine.

[38]  D. S. Coffey,et al.  The role of androgens and estrogens in the pathogenesis of experimental nonbacterial prostatitis. , 1988, The Journal of urology.

[39]  L. Baert,et al.  Chronic bacterial prostatitis: 10 years of experience with local antibiotics. , 1988, The Journal of urology.

[40]  W. A. Gardner,et al.  Trichomonas vaginalis in the prostate gland. , 1986, Archives of pathology & laboratory medicine.

[41]  M. Toni,et al.  Isolation of Chlamydia trachomatis from the prostatic cells in patients affected by nonacute abacterial prostatitis. , 1985, The Journal of urology.

[42]  W. Weidner,et al.  Studies on the role of Ureaplasma urealyticum and Mycoplasma hominis in prostatitis. , 1983, The Journal of infectious diseases.

[43]  R. Kirby,et al.  Intra-prostatic urinary reflux: an aetiological factor in abacterial prostatitis. , 1982, British journal of urology.

[44]  W. Krause,et al.  Quantitative culture of ureaplasma urealyticum in patients with chronic prostatitis or prostatosis. , 1980, The Journal of urology.

[45]  J. Jenkins,et al.  The painful prostate. , 1975, British journal of urology.

[46]  T. Stamey,et al.  Bacteriologic localization patterns in bacterial prostatitis and urethritis. , 1968, Investigative urology.

[47]  R. Burgut,et al.  Lower urinary tract symptoms, pain and quality of life assessment in chronic non-bacterial prostatitis patients treated with α-blocking agent doxazosin; versus placebo , 2004, International Urology and Nephrology.

[48]  F. Gallo,et al.  Role of mepartricin in category III chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized prospective placebo-controlled trial. , 2004, Urology.

[49]  T. Wilt,et al.  Diagnosis and treatment of chronic abacterial prostatitis: a systematic review. , 2000, Annals of internal medicine.

[50]  D. Bostwick,et al.  Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. , 1998, Urology.

[51]  J. J. de la Rosette,et al.  Research in 'prostatitis syndromes': the use of alfuzosin (a new alpha 1-receptor-blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities. , 1992, European urology.

[52]  H. Wedrén Effects of sodium pentosanpolysulphate on symptoms related to chronic non-bacterial prostatitis. A double-blind randomized study. , 1987, Scandinavian journal of urology and nephrology.